Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.795
+0.015 (0.54%)
At close: Jul 20, 2026, 4:00 PM EDT
2.800
+0.005 (0.16%)
After-hours: Jul 20, 2026, 7:48 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $325.78 million as of July 20, 2026. Its market cap has increased by 151.57% in one year.
Market Cap
325.78M
Enterprise Value
227.75M
1-Year Change
151.57%
Ranking
Category
Stock Price
$2.80
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $325.78M, an increase of 158.35%. That is a compound annual growth rate of 7.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 325.78M | 187.29% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 359.59M |
| Palisade Bio | 341.95M |
| Vicore Pharma Holding AB | 331.80M |
| Vanda Pharmaceuticals | 327.14M |
| Eledon Pharmaceuticals | 314.62M |
| Lyell Immunopharma | 310.81M |
| OmniAb | 307.34M |
| Foghorn Therapeutics | 304.73M |